ClinChoice
Shanghai
About ClinChoice
ClinChoice Kunling was established in Tianjin inSince its establishment, through its own organic growth and strategic mergers and acquisitions, ClinChoice has more than 3,000 clinical R&D professionals around the world, located in hot cities and regions of domestic and foreign pharmaceutical R&D, and has developed into a local clinical CRO enterprise model supporting innovative drug device R&D. . The company adheres to the connotation of "Kunxing Zhiyuan · Ling creates the future", which means to become an ideal partner for the clinical research and development of innovative pharmaceutical devices.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1,001 – 5,000
- Total funding: $212.0M
- Funding stage: Late Stage Venture
- Last round: Series E (Jul 2022)
- Website: clinchoice.com.cn
- Phone: +86-226-520-8088
Industries & Categories
Biotechnology, Consulting, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/clinchoice-81639 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.